In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ 13.28 ...

The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...

DNA Sequencing Market Fueled by Genomics Research, Personalized Medicine, and AI-Powered Advancements, the DNA Sequencing <a target=_blank ...

Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...